Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Transplant”

1,194 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,194 results

Testing effectiveness (Phase 2)Study completedNCT00427557
What this trial is testing

Cellular Therapy With Cord Blood Cells

Who this might be right for
Multiple MyelomaLeukemiaLymphoma
M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)UnknownNCT05143892
What this trial is testing

Avatrombopag to Promote Platelet Engraftment After Allo-HSCT

Who this might be right for
Platelet Disorder
The First Affiliated Hospital of Soochow University 20
Not applicableLooking for participantsNCT05947864
What this trial is testing

Monitoring of Measles-specific Immune Status in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
Transplantation, Hematopoietic Stem Cell
Hospices Civils de Lyon 60
Large-scale testing (Phase 3)Looking for participantsNCT07389616
What this trial is testing

A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 40
Testing effectiveness (Phase 2)UnknownNCT05809167
What this trial is testing

Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University 55
Early research (Phase 1)Looking for participantsNCT03326921
What this trial is testing

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Who this might be right for
Juvenile Myelomonocytic LeukemiaRecurrent Acute Biphenotypic LeukemiaRecurrent Acute Undifferentiated Leukemia+26 more
Fred Hutchinson Cancer Center 24
Large-scale testing (Phase 3)UnknownNCT00215007
What this trial is testing

Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

Who this might be right for
MalignancyAllogeneic Stem Cell Transplantation
Charite University, Berlin, Germany
Early research (Phase 1)Active Not RecruitingNCT04098393
What this trial is testing

Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Memorial Sloan Kettering Cancer Center 39
Not applicableUnknownNCT05656599
What this trial is testing

Immune Reconstitution to CMV After HSCT: Impact of Clinical Factors and Therapy Strategies

Who this might be right for
CMV InfectionHematopoietic Stem Cell Transplantation
Peking University People's Hospital 120
Not applicableStudy completedNCT05972577
What this trial is testing

Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+9 more
Ohio State University Comprehensive Cancer Center 30
Not applicableUnknownNCT01255319
What this trial is testing

Cyclophosphamide, Fludarabine and Antithymocyte Globulin Conditioning in Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndrome
Cooperative Study Group A for Hematology 15
Testing effectiveness (Phase 2)Ended earlyNCT04530487
What this trial is testing

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

Who this might be right for
Desmoplastic Small Round Cell TumorEwing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Desmoplastic Small Round Cell Tumor+9 more
M.D. Anderson Cancer Center 1
Not applicableEnded earlyNCT03557749
What this trial is testing

Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies

Who this might be right for
Immune and Microbial ReconstitutionSystemic Viral InfectionAcute-graft-versus-host Disease+5 more
Masonic Cancer Center, University of Minnesota 210
Testing effectiveness (Phase 2)UnknownNCT04677868
What this trial is testing

MTX and Steroid for aGVHD Treatment

Who this might be right for
Acute GVH Disease
Peking University People's Hospital 30
Large-scale testing (Phase 3)UnknownNCT05256693
What this trial is testing

Prevention of C.Difficile Infections With Oral Vancomycine in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
Clostridium Difficile InfectionsStem Cell Transplant Complications
Assistance Publique - Hôpitaux de Paris 336
Not applicableNot Yet RecruitingNCT06385808
What this trial is testing

Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML

Who this might be right for
Relapse LeukemiaRefractory Acute Myeloid LeukemiaConditioning+1 more
First Affiliated Hospital Xi'an Jiaotong University 37
Testing effectiveness (Phase 2)Looking for participantsNCT07148947
What this trial is testing

Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms

Who this might be right for
Accelerated Phase Myeloproliferative NeoplasmBlast Phase Myeloproliferative Neoplasm
University of Washington 27
Testing effectiveness (Phase 2)Looking for participantsNCT03728335
What this trial is testing

Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation

Who this might be right for
Acute Myeloid Leukemia
City of Hope Medical Center 35
Testing effectiveness (Phase 2)Looking for participantsNCT07304232
What this trial is testing

Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation (HCT)AML (Acute Myeloid Leukemia)
Institute of Hematology & Blood Diseases Hospital, China 134
Testing effectiveness (Phase 2)Looking for participantsNCT04554914
What this trial is testing

Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Who this might be right for
Epstein-Barr Virus (EBV)-Associated DiseasesEBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD)EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD)+8 more
Pierre Fabre Medicament
Load More Results
190